Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,376
Closed -$362K 847
2022
Q3
$362K Sell
4,376
-2,540
-37% -$223K 0.01% 630
2022
Q2
$553K Sell
6,916
-70
-1% -$7.08K 0.01% 576
2022
Q1
$790K Sell
6,986
-187
-3% -$21K 0.01% 530
2021
Q4
$816K Buy
7,173
+1,559
+28% +$168K 0.01% 491
2021
Q3
$653K Sell
5,614
-1,032
-16% -$129K 0.01% 516
2021
Q2
$800K Buy
6,646
+546
+9% +$64.6K 0.02% 425
2021
Q1
$657K Buy
6,100
+2,451
+67% +$272K 0.01% 477
2020
Q4
$428K Buy
+3,649
New +$372K 0.01% 538
2014
Q2
Sell
-410
Closed -$28K 778
2014
Q1
$28K Sell
410
-5,400
-93% -$359K ﹤0.01% 391
2013
Q4
$368K Buy
+5,810
New +$341K 0.05% 174
2013
Q3
Sell
-208,152
Closed -$12.6M 162
2013
Q2
$12.6M Buy
+208,152
New +$13M 2.51% 8

Other funds holding DVA

Colony Group's DVA Position: Q4 2022 in Review

Colony Group sold out of DaVita (DVA) in Q4 2022, closing a stake of 4,376 shares — an estimated $362K sold.

Colony Group first reported a position in DVA in Q2 2013 and held it in 11 quarters. The position peaked at $12.6M in Q2 2013. 444 funds tracked by Wall St. Rank hold DVA as of Q4 2022.

  • Colony Group reported no remaining DaVita position as of Q4 2022 after selling out during the quarter.
  • Colony Group sold 4,376 DaVita shares in Q4 2022, an estimated $362K.
  • Colony Group first reported a position in DaVita in Q2 2013 and held it in 11 quarters.
  • Colony Group's DaVita position peaked at $12.6M in Q2 2013.
  • 444 funds tracked by Wall St. Rank held DaVita as of Q4 2022.

Based on Colony Group's 13F filing for Q4 2022, filed 14 Feb 2023.